A Service For Professionals Friday, October 20, 2017
Contact (202) 540-8337
Company News Today
A Service For Professionals Friday, October 20, 2017 11614 Sources 410,795,539 Articles 3,134,516 Readers
Contact (202) 540-8337

Depomed to Report Second Quarter 2017 Financial Results on Monday, August 7, 2017

NEWARK, Calif., July 31, 2017 (GLOBE NEWSWIRE) -- Depomed, Inc. (NASDAQ:DEPO) today announced that it will release second quarter fiscal year 2017 financial results on Monday, August 7, 2017, after the close of markets. The Company will host a conference call beginning at 4:30 p.m. EDT (1:30 p.m. PDT) to discuss its results.

/EIN News/ -- Participants can access the call by dialing (866) 643-3010 (United States) or (857) 270-6032 (International) referencing Conference ID 61913049. The conference call will also be available via a live webcast on the Investor Relations section of Depomed's website at http://www.depomed.com. Please access the website 15 minutes prior to the start of the call to download and install any necessary audio software. An archived webcast replay will be available on the Company's website for three months.

About Depomed

Depomed is a leading specialty pharmaceutical company focused on enhancing the lives of the patients, families, physicians, providers and payors we serve through commercializing innovative products for pain and neurology related disorders. Depomed markets six medicines with areas of focus that include mild to severe acute pain, moderate to severe chronic pain, neuropathic pain, migraine and breakthrough cancer pain. Depomed is headquartered in Newark, California. To learn more about Depomed, visit www.depomed.com.

INVESTOR AND MEDIA CONTACT:
                    Christopher Keenan
                    VP, Investor Relations and Corporate Communications
                    510-744-8000
                    ckeenan@depomed.com

Primary Logo

Powered by EIN News